Follow us on:
Breaking News
June 29, 2026
Breaking News
Breaking News

Elevating Quality and Compliance in Sterile Injectable Fill-Finish

 
Elevating Quality and Compliance in Sterile Injectable Fill-Finish

Sterile injectables are transforming patient care, but with rising complexity and tighter regulations, delivering them safely and at scale is more challenging than ever.
Read More >>

Recent Headlines

Breaking News
Collaborations & Alliances

Adragos Pharma Kawagoe, Towa Pharmaceutical Ink Strategic Supply Pact 

Adragos will manufacture and supply up to 1.5 billion tablets per year for Towa Pharmaceutical from its Kawagoe plant in Japan.

SPONSOR

Scale Dry Powder Media to cGMP with Confidence

Discover a proven two-phase strategy to scale dry powder media while ensuring quality, consistency, and seamless tech transfer.

Breaking News

Enzene Premieres Nex Partnership Program at BIO 2026

The company will also soon be expanding its New Jersey manufacturing facility.

Breaking News

SK pharmteco Launches SKyvec Proprietary Multimodal Viral Vector Platform

The platform unites three core modalities into a single offering that affords flexibility for therapeutics developers.

SPONSOR

Unique Products, Unique Solutions: Why Flexible, Tailored CDMO Support is a Non-Negotiable in Sterile Fill-Finish

Learn how the right CDMO partnership reduces risk, accelerates timelines, and protects product integrity from vial to patient.

SGS_Webinar_07-16-26_650x250

Breaking News
Collaborations & Alliances

Roche, Excalipoint to Collaborate on Evaluation of Candidate for Solid Tumors

Roche will supply atezolizumab to be used in proposed clinical studies.

SPONSOR

The Hidden Carbon Cost of Stainless Steel Equipment

Why the environmental impact of manufacturing pharmaceutical equipment often goes unmeasured—and how procurement teams can start accounting for it.  

Featured Resources

Solution Center SPOTLIGHT

CMC Pharmaceuticals

CMC Pharma expedites drug product development with flexible lab services tailored to every stage of development. FDA-registered and inspected labs are equipped to conduct both routine & customized drug product development studies to ensure the purity and potency of the finished drug product through product approval and commercialization.

 

Solution Center SPOTLIGHT

Suanfarma CDMO

Suanfarma CDMO provides integrated, end-to-end solutions for development and commercialization services of Intermediates and Drug Substances for Small Molecules. We specialize helping pharmaceutical, biotech and healthcare companies delivering full integrated services that compress timelines to market maximizing success. We have the best know-how and technologies to carry out fermentation, purification, and chemical synthesis processes in our CDMO plants including Regulatory support.